| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1212/WNL.42.10.1944 |
| P698 | PubMed publication ID | 1407577 |
| P2093 | author name string | Newsom-Davis J | |
| B. Lang | |||
| C. B. Saper | |||
| I. Johnston | |||
| J. B. Posner | |||
| J. Newsom-Davis | |||
| P. D. Clouston | |||
| T. Arbizu | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1944-1950 | |
| P577 | publication date | 1992-10-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome | |
| P478 | volume | 42 |
| Q26786113 | 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC |
| Q75379699 | A case of Parinaud's syndrome due to the remote effect of small cell carcinoma |
| Q40956175 | Adenocarcinoma of the prostate and Eaton-Lambert syndrome. A previously unreported association |
| Q42107804 | Alcohol-responsive Action Myoclonus of the Leg in Prostate Cancer: A Novel Paraneoplastic Syndrome? |
| Q36497513 | Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo |
| Q48247436 | Antibodies against the beta subunit of voltage-dependent calcium channels in Lambert-Eaton myasthenic syndrome. |
| Q36233083 | Antibody-mediated disorders of neuromuscular transmission. |
| Q36774744 | Autoimmune and paraneoplastic channelopathies |
| Q41270524 | Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options |
| Q35018526 | Autoimmune encephalopathy and drug refractory seizures with the presence of two autoantibodies specific for the neuronal cell surface. |
| Q34404847 | Autonomic dysfunction in Lambert-Eaton myasthenic syndrome. |
| Q34582727 | Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders |
| Q37807591 | Clinical presentation of immune-mediated cerebellar ataxia |
| Q48162535 | Lambert-Eaton myasthenic syndrome and prostatic adenocarcinoma. |
| Q28346582 | Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer |
| Q33899113 | Mental neuropathy: report of five cases and review of the literature |
| Q72351959 | Multiple paraneoplastic syndromes in a patient with antibodies to neuronal nucleoproteins (anti-Hu) |
| Q41725494 | Neurologic paraneoplastic syndromes |
| Q37032830 | Neuronal autoantigens--pathogenesis, associated disorders and antibody testing |
| Q84338959 | Opsoclonus-myoclonus with multiple paraneoplastic syndromes and VGCC antibodies |
| Q40807263 | Paraneoplasia and autoimmunologic injury of the nervous system: the anti-Hu syndrome |
| Q90374632 | Paraneoplastic Cerebellar Degeneration Associated With Ovarian Adenocarcinoma: A Case Report and Review of Literature |
| Q73904157 | Paraneoplastic cerebellar degeneration as the first evidence of cancer: a case report |
| Q42011663 | Paraneoplastic cerebellar degeneration associated with noncutaneous Merkel cell carcinoma |
| Q48382775 | Paraneoplastic cerebellar degeneration with a circulating antibody against neurons and non-neuronal cells |
| Q71542050 | Paraneoplastic neurologic syndromes |
| Q35172434 | Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy |
| Q41535384 | Paraneoplastic neuromuscular syndromes |
| Q38833910 | Paraneoplastic syndromes (PNS) associated with Merkel cell carcinoma (MCC): A case series of 8 patients highlighting different clinical manifestations |
| Q37817730 | Paraneoplastic syndromes in prostate cancer. |
| Q34096509 | Paraneoplastic syndromes of the spinal cord, nerve, and muscle |
| Q36682468 | Peripheral nervous system involvement in patients with cancer |
| Q89048163 | Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes |
| Q34344320 | Rehabilitation of patients with advanced cancer |
| Q34469061 | Remote neurologic manifestations of cancer |
| Q33524955 | Sporadic ataxia with adult onset: classification and diagnostic criteria |
| Q33733170 | Subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with antibodies to voltage-gated calcium channels: differential effect of immunosuppressive therapy on central and peripheral defects |
| Q36389693 | The European LEMS Registry: Baseline Demographics and Treatment Approaches |
| Q51838886 | Treatment options in paraneoplastic disorders of the peripheral nervous system. |
| Q42718371 | Understanding the physiopathology of paraneoplastic and genetic cerebellar ataxia |
| Q39889728 | Voltage-gated calcium channel autoimmune cerebellar degeneration: Case and study of cytotoxicity. |
| Q59530617 | Voltage-gated calcium channels, calcium signaling, and channelopathies |
Search more.